SAM
EVH icon

Silvercrest Asset Management’s Evolent Health EVH Stock Holding History

Silvercrest Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,799,081
Closed -$15.2M – 867
2025
Q3 		$15.2M Buy
1,799,081
+18,227
+1% +$177K 0.1% 250
2025
Q2 		$20.1M Buy
1,780,854
+51,429
+3% +$472K 0.13% 201
2025
Q1 		$16.4M Buy
1,729,425
+358,372
+26% +$3.62M 0.12% 212
2024
Q4 		$15.4M Buy
1,371,053
+372,793
+37% +$6.55M 0.1% 222
2024
Q3 		$28.2M Buy
998,260
+270,602
+37% +$6.97M 0.19% 159
2024
Q2 		$13.9M Sell
727,658
-6,828
-0.9% -$174K 0.1% 215
2024
Q1 		$24.1M Sell
734,486
-185,819
-20% -$5.93M 0.16% 164
2023
Q4 		$30.4M Sell
920,305
-89,762
-9% -$2.54M 0.22% 142
2023
Q3 		$27.5M Buy
1,010,067
+115,516
+13% +$3.21M 0.21% 143
2023
Q2 		$27.1M Buy
894,551
+59,596
+7% +$1.93M 0.19% 149
2023
Q1 		$27.1M Buy
834,955
+91,792
+12% +$2.9M 0.21% 141
2022
Q4 		$20.9M Sell
743,163
-78,731
-10% -$2.26M 0.16% 156
2022
Q3 		$29.5M Sell
821,894
-33,937
-4% -$1.2M 0.24% 129
2022
Q2 		$26.3M Sell
855,831
-11,254
-1% -$328K 0.2% 149
2022
Q1 		$28M Sell
867,085
-4,656
-0.5% -$122K 0.18% 154
2021
Q4 		$24.1M Buy
871,741
+1,045
+0.1% +$30K 0.15% 161
2021
Q3 		$27M Sell
870,696
-349,289
-29% -$8.39M 0.18% 152
2021
Q2 		$25.8M Buy
1,219,985
+64,454
+6% +$1.29M 0.17% 162
2021
Q1 		$23.3M Sell
1,155,531
-679,302
-37% -$12.9M 0.16% 169
2020
Q4 		$29.4M Buy
1,834,833
+93,263
+5% +$1.23M 0.21% 139
2020
Q3 		$21.6M Sell
1,741,570
-56,108
-3% -$660K 0.19% 144
2020
Q2 		$12.8M Buy
1,797,678
+227,401
+14% +$1.52M 0.11% 181
2020
Q1 		$8.53M Sell
1,570,277
-528,341
-25% -$4.72M 0.09% 211
2019
Q4 		$19M Buy
2,098,618
+58,033
+3% +$471K 0.15% 163
2019
Q3 		$14.7M Buy
+2,040,585
New +$14.6M 0.12% 181

Other funds holding EVH

CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Silvercrest Asset Management's EVH Position: Q4 2025 in Review

Silvercrest Asset Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 1,799,081 shares — an estimated $15.2M sold.

Silvercrest Asset Management first reported a position in EVH in Q3 2019 and held it in 25 quarters. The position peaked at $30.4M in Q4 2023. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Silvercrest Asset Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • Silvercrest Asset Management sold 1,799,081 Evolent Health shares in Q4 2025, an estimated $15.2M.
  • Silvercrest Asset Management first reported a position in Evolent Health in Q3 2019 and held it in 25 quarters.
  • Silvercrest Asset Management's Evolent Health position peaked at $30.4M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Silvercrest Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.